XBiotech has appointed Jan-Paul Simard as Co-Chief Executive Officer alongside current CEO Dr. Sushma Shivaswamy, effective October 23, 2026. This leadership change aims to combine their complementary skills and scientific expertise to advance XBiotech's antibody therapies. Dr. Shivaswamy has been with the company for 17 years and served as interim CEO since December 2025. Simard, with a background in clinical development and chemistry, will support strategic execution and operational continuity as the company pushes forward with its drug pipeline.
XBiotech's leadership update provides context for readers following health sector stocks. For readers following health sector stocks, here is Pluang's market snapshot as of Oct 23, 2026 20:21 WIB: Among 150 priced US health stocks, 28 rose and 119 fell today. TNGX traded at USD 25.63 with a 1-day change of -8.23% and saw 100% buy orders on Pluang with a typical hold time of 2 days, contrasting with MRNA at USD 193.00 down 4.75% with 71% sell orders and a much longer hold time of 58 days. NUVB rose 3.19% to USD 4.85 with a typical hold time of 7 days.
FS Bancorp, Inc. has appointed Matthew D. Mullet as a director on the boards of both the company and its bank, 1st Security Bank of Washington, effective October 22, 2026. Mullet, who has been President since 2024 and CEO since 2025-2026, brings exte...
The global protein ingredients market, valued at $42.3 billion in 2025, is projected to grow to $65 billion by 2032 with a CAGR of 6.3%. Growth is driven by rising consumer demand for health-focused, protein-enriched foods, sports nutrition, and sust...
AX1 has launched Console 2.0, a platform on the Base blockchain that lets AI agents perform tasks and get paid in USDC using the x402 payment standard by Coinbase. This new version simplifies setup, allowing users to deploy AI agents quickly to work ...
The global generator cooling systems market is projected to grow from $3.76 billion in 2026 to $5.03 billion by 2031 at a CAGR of 6.0%. Growth is fueled by rising demand for reliable backup and continuous power in expanding data centers, industrial f...
The global computed tomography (CT) market is undergoing significant innovation driven by photon-counting technology, AI integration, mobile imaging, and point-of-care applications. These advancements are enhancing image quality, workflow efficiency,...
